Latest News & Updates

Breaking News

  • 5 hours ago

  • Vaibhavi M.

Medicus Pharma Elevates President Carolyn Bonner To Chief Financial Officer To Strengthen Strategic And Financial Leadership
Breaking News
Regeneron And Tessera Therapeutics Establish Global Collaboration Accelerate Development Of TSRA-196, A One-Time Gene Correction Therapy For Alpha-1 Antitrypsin Deficiency

Vaibhavi M.

Other trending news you may like to read

Medicus Pharma Elevates President Carolyn Bonner To Chief Financial Officer To Strengthen Strategic And Financial Leadership

Medicus Pharma appoints President Carolyn Bonner as CFO, strengthening leadership continuity as the company advances its clinical development programs.

Vaibhavi M.

Pharma Now

Regeneron And Tessera Therapeutics Establish Global Collaboration Accelerate Development Of TSRA-196, A One-Time Gene Correction Therapy For Alpha-1 Antitrypsin Deficiency

Regeneron and Tessera partner to advance TSRA-196, a one-time Gene Writing therapy targeting the root cause of alpha-1 antitrypsin deficiency.

Vaibhavi M.

Pharma Now

Kiora Pharmaceuticals Secures New U.S. Patent Strengthening KIO-104 Formulation And Delivery Options

Kiora secures a new USPTO patent for KIO-104’s novel formulation, supporting its Phase 2 development for retinal inflammation and macular edema treatment.

Vaibhavi M.

Pharma Now

Sanofi & Regeneron’s Dupixent Secures EU Approval, Marking The First Targeted Therapy For Chronic Spontaneous Urticaria In 10 Years

EU approves Dupixent for moderate-to-severe chronic spontaneous urticaria, offering a first-line biologic option for patients uncontrolled on antihistamines.

Simantini Singh Deo

Pharma Now